MAPT and supranuclear palsy, progressive, 1: The fact that the oculomotor criteria alone—although they are the eponymous feature—were not sufficient to identify each and every patient is in line with the established procedure of the multifaceted syndromal diagnostic pathway in PSP, given that the diagnostic accuracy has gained further importance now that several therapeutic approaches, often directly targeting tau pathology, are being investigated in clinical trials [33].